InvestorsHub Logo
Followers 123
Posts 12252
Boards Moderated 0
Alias Born 11/08/2021

Re: exwannabe post# 665798

Sunday, 01/21/2024 12:57:09 PM

Sunday, January 21, 2024 12:57:09 PM

Post# of 717282

Others have played the game of saying that despite the failure of the randomized trial the drug worked



It's hard to give any weight to an argument built on blatant and repeated lies. Dr. Liau stated 29 patients were in the control but most died early or were lost to followup. Not only do you pretend to know the data on the 29 that hasn't been disclosed and likely would be contrary to your point if disclosed, but you push the blatant lie that the cross over was part of the control. When you take DCVax-L you are no longer part of the control. This is basic knowledge, yet something you purposely overlook everytime you push this lie. The patients that had a recurrence and choose to take DCVax-L formed the rGBM arm of the trial. The never before seen rGBM data will allow NWBO to nearly double their patient population. This is a poor attempt to twist successful rGBM data into a trial failure. You claim to be here to protect unsuspecting shareholders but I don't understand how repeating a lie portraying success as failure helps the shareholders.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News